Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials

Authors:

Abstract
No abstract available
Funding Information
  • Idorsia Pharmaceuticals Ltd

This publication has 24 references indexed in Scilit: